Why is Vaishali Pharma falling/rising?

As of 03-Sep, Vaishali Pharma Ltd's stock price is currently at 12.16, reflecting a decrease of 0.03 or 0.25%. The stock has shown a mixed performance recently, with a 1-week return of +2.27%, but it has underperformed over the past month with a decline of -4.25%. Today's price summary indicates that the stock has underperformed its sector by 1.49%, and while it is trading above its 5-day moving average, it remains below the 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 66.78% compared to the 5-day average. The company has a concerning long-term outlook, evidenced by a -145.73% CAGR growth in operating profits over the last five years and a weak ability to service its debt, which negatively impacts investor sentiment.
In the broader market context, the stock's recent performance contrasts with the benchmark, as it has generated a return of -30.47% year-to-date, while the Sensex has increased by 4.53%. This underperformance is further highlighted by the stock's negative EBITDA and a significant drop in profits over the past year, which has contributed to its overall decline. The company's flat results in June, with a PAT of Rs 1.28 crore falling by -24.7%, along with a low return on equity of 8.96%, indicate weak profitability and have likely deterred investors. Overall, the combination of poor financial performance, declining investor interest, and unfavorable comparisons to the benchmark has led to the stock's downward movement.